Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 4, 2017

View Archived Issues

Medsenic's arsenic trioxide awarded E.U. orphan drug designation for GvHD, begins phase II trial

Novel prototypical peptidomimetic inhibitor demonstrates efficacy in models of AML

IMPDH inhibition as a promising new therapeutic strategy against MLL-fusion leukemia

AMPK identified as a novel therapeutic target in acute lymphoblastic leukemia

Researchers identify a novel target for AML and MDS

Xenikos obtains funding to support T-Guard development

Flamel Technologies now Avadel Pharmaceuticals

Axsome Therapeutics cleared to begin phase II/III study of AXS-05 in Alzheimer's

Bayer Pharma patents muscarinic acetylcholine M2 receptor PAMs

University of Florida discloses aminoacyl-tRNA synthetase inhibitors

Zynerba Pharmaceuticals commences FAB-C study of ZYN-002 gel

Abeona Therapeutics' ABO-201 granted orphan drug designation in Europe

Inventiva initiates patient enrollment in phase IIb study of IVA-337

Almirall describes JAK inhibitors

Soliqua available in U.S.

Adhaere Pharmaceuticals presents anticancer agents

Kite Pharma submits IND for phase I study of KITE-718

GSK closes agreement to divest non-core assets to Aspen

FDA grants priority review to Stivarga sNDA for hepatocellular carcinoma

Astellas Pharma discloses dopamine D1 receptor PAMs

Seattle Genetics presents new clinical data for vadastuximab talirine

Agile reports phase III topline results for Twirla hormonal contraceptive patch

Newron Pharmaceuticals reports promising results for evenamide in schizophrenia

Inspyr Therapeutics to study mipsagargin combination therapies

NewVac's phase II study of quisinostat meets primary endpoints

Inotek reports topline results from pivotal trial of trabodenoson for glaucoma

Acura explores financing and strategic alternatives

CymaBay Therapeutics signs license agreement with Kowa for arhalofenate in U.S.

Cellectis submits IND to begin phase I trials of UCART-123

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 4, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...